CNDO: Fortress Biotech, Inc. Press Release: Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain

New alert via PocketInfo for CNDO:

Fortress Biotech, Inc. Press Release: Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain

Press Releases: http://ir.coronadobiosciences.com/news.aspx?iid=4308955
SEC Filings: http://ir.coronadobiosciences.com/docs.aspx?iid=4308955
Stock News Alerts by Pocket Info - the app
Our free iPhone and iPad app lets you choose just the tickers you care about from over 2000 US companies and get alerts to your screen
https://itunes.apple.com/sg/app/stock-news-alerts/id708293183?mt=8